The cost of preterm birth and cesarean section as a result of infertility and its treatment: A review

Best Pract Res Clin Obstet Gynaecol. 2023 Feb:86:102304. doi: 10.1016/j.bpobgyn.2022.102304. Epub 2022 Dec 27.

Abstract

Infertility, irrespective of receipt of fertility treatment, is associated with an increased risk of adverse pregnancy outcomes, including cesarean section (CS) and preterm birth (PTB). These complications are associated with significant physical, mental, emotional, social, and financial costs to individuals, healthcare systems, and society at large. Although multiple pregnancy is one of the most significant contributors to the elevated CS and PTB rates in women receiving fertility treatment, singleton pregnancy is also at an increased risk of these outcomes. Single embryo transfer policies through publicly funded in vitro fertilization programs have demonstrated beneficial health outcomes and cost savings. Low-dose aspirin prophylaxis may be considered for PTB reduction in patients with infertility. Finally, upstream prevention strategies such as lifestyle modification and social policies to address the underlying needs for fertility treatment may also beneficially impact both CS and PTB rates.

Keywords: Assisted reproductive technology; Cesarean section; Cost analysis; Infertility; Preterm birth.

Publication types

  • Review

MeSH terms

  • Cesarean Section
  • Female
  • Fertilization in Vitro / adverse effects
  • Humans
  • Infant, Low Birth Weight
  • Infant, Newborn
  • Infertility* / therapy
  • Pregnancy
  • Pregnancy Outcome
  • Premature Birth* / etiology
  • Premature Birth* / prevention & control